Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Eupraxia Pharmaceuticals Inc (TO: EPRX)

 
EPRX Technical Analysis
5
As on 22nd Dec 2025 EPRX STOCK Price closed @ 9.70 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 6.09 & Strong Buy for SHORT-TERM with Stoploss of 4.51 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

EPRXSTOCK Price

Open 9.05 Change Price %
High 10.10 1 Day 0.59 6.48
Low 9.04 1 Week 0.84 9.48
Close 9.70 1 Month 1.02 11.75
Volume 186466 1 Year 4.91 102.51
52 Week High 9.70 | 52 Week Low 4.12
 
TO Canada Most Active Stocks
YRI 7.89 0.13%
TLO 0.61 8.93%
CNQ 44.48 1.11%
BTO 6.60 4.60%
CVE 23.01 -0.09%
UEX 0.50 16.28%
T 17.40 -0.11%
MFC 50.24 0.64%
WEED 1.84 -9.80%
ABX 62.71 1.77%
 
TO Canada Top Gainers Stocks
ONC 16.90 1090.14%
ONC 16.90 1090.14%
CUB 0.21 950.00%
CUB 0.21 950.00%
AOI 13.38 611.70%
AOI 13.38 611.70%
GGA 0.03 50.00%
MIN 0.20 42.86%
MIN 0.20 42.86%
MIN 0.20 42.86%
 
TO Canada Top Losers Stocks
MOZ 0.16 -80.25%
MOZ 0.16 -80.25%
SMC 0.02 -33.33%
SMC 0.02 -33.33%
SMC 0.02 -33.33%
SMC 0.02 -33.33%
SMC 0.02 -33.33%
LEV 0.34 -29.17%
LEV 0.34 -29.17%
LEV 0.34 -29.17%
 
 
EPRX
Daily Charts		 EPRX
Intraday Charts		 Whats New @
Bazaartrend		 EPRX
Free Analysis
 
EPRX Important Levels Intraday
RESISTANCE11.74
RESISTANCE11.09
RESISTANCE10.68
RESISTANCE10.28
SUPPORT9.12
SUPPORT8.72
SUPPORT8.31
SUPPORT7.66
 
EPRX Forecast December 2025
Share
4th UP Forecast10.99
3rd UP Forecast10.58
2nd UP Forecast10.32
1st UP Forecast10.07
1st DOWN Forecast9.33
2nd DOWN Forecast9.08
3rd DOWN Forecast8.82
4th DOWN Forecast8.41
 
EPRX Weekly Forecast
4th UP Forecast10.57
3rd UP Forecast10.29
2nd UP Forecast10.12
1st UP Forecast9.95
1st DOWN Forecast9.45
2nd DOWN Forecast9.28
3rd DOWN Forecast9.11
4th DOWN Forecast8.83
 
EPRX Forecast2025
4th UP Forecast21.53
3rd UP Forecast17.74
2nd UP Forecast15.39
1st UP Forecast13.05
1st DOWN Forecast6.35
2nd DOWN Forecast4.01
3rd DOWN Forecast1.66
4th DOWN Forecast-2.13
 
 
EPRX Other Details
Segment EQ
Market Capital 30621592.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
EPRX Address
EPRX
 
EPRX Latest News
 
Your Comments and Response on Eupraxia Pharmaceuticals Inc
 
EPRX Business Profile
Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis, as well as under development for treating canine and equine osteoarthritis. Its products in development also include EP-201, an antibiotic for post-surgical site infections; and EP-105, an extended-release post-surgical anesthetic for post-surgical pain. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada. Address: 2067 Cadboro Bay Road, Victoria, BC, Canada, V8R 5G4
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service